Published and preliminary data have shown once-weekly exenatide to result in greater A1c reduction ... these medications fit into our algorithm for effectively managing Type 2 diabetes.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

GLP-1 agonist medications ... is approved for adults with type 2 diabetes to improve blood sugar levels when combined with diet and exercise. A1C levels dropped by 1.0% to 1.3%.